Pacira Pharmaceuticals Inc.
- BID
22.6
- ASK
23
- 1,329 Units1,305 Units
- 07/24, 12:03:33 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
19.15%
Market Cap
-
P/E Ratio
165.69
Dividend Yield
0.00 %
Earnings per Share
0.14 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 22.6 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 12:03:33 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 22.6 | 22.4 |
| PREV. DAY'S PRICE | 22.6 | (07/23) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 23.2 (07/07) | 15.5 (01/19) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.75 | -1.99 | 0.14 | 2.57 | 3.25 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 41.80 | - | 165.69 | 8.81 | 6.96 |
PRICE - BOOK RATIO | 1.80 | 1.12 | 1.54 | - | - |
PRICE - SALES RATIO | 2.60 | 1.24 | 1.60 | - | - |
PRICE - CASH FLOW RATIO | 11.34 | 4.60 | 7.67 | - | - |
Master Data
| WKN | A1H68T |
| ISIN | US6951271005 |
| SYMBOL | 82P |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | PACIRA BIOSCIENC. DL-,001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.82 % | 13.71 % | 6.67 % | 26.55 % | 19.15 % | -31.71 % | -54.29 % | 3.70 % |
| HIGH | 22.80 | 23.20 | 23.20 | 23.20 | 23.20 | 36.40 | 74.00 | 23.20 |
| LOW | 21.60 | 19.10 | 18.80 | 16.10 | 15.50 | 10.20 | 10.20 | 15.50 |
Dividende
pro Aktie
PACIRA BIOSCIENC. DL-,001 does not deliver dividend information
Company profile
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.
Structured products for Pacira Pharmaceuticals Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.